Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
2.070
-0.090 (-4.17%)
At close: Apr 2, 2025, 4:00 PM
2.234
+0.164 (7.92%)
After-hours: Apr 2, 2025, 6:30 PM EDT

Lisata Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-19.99-20.84-54.23-27.47-8.15
Upgrade
Depreciation & Amortization
0.170.190.070.060.06
Upgrade
Loss (Gain) From Sale of Assets
-0---
Upgrade
Asset Writedown & Restructuring Costs
--30.39--
Upgrade
Loss (Gain) From Sale of Investments
-0.46-0.960.792.510.31
Upgrade
Loss (Gain) on Equity Investments
0.13----
Upgrade
Stock-Based Compensation
1.652.042.642.011.27
Upgrade
Other Operating Activities
----0.01
Upgrade
Change in Accounts Receivable
-0.9----
Upgrade
Change in Accounts Payable
-10.09-0.221.25-2.84
Upgrade
Change in Other Net Operating Assets
1.02-0.55-0.61-0.60.52
Upgrade
Operating Cash Flow
-19.36-20.03-21.17-22.25-8.82
Upgrade
Capital Expenditures
---0.29-0.06-0.02
Upgrade
Cash Acquisitions
---3.32--
Upgrade
Investment in Securities
13.2310.132.52-54.84-7.26
Upgrade
Investing Cash Flow
13.2310.128.91-54.9-7.28
Upgrade
Issuance of Common Stock
0.070.480.0485.5218.73
Upgrade
Repurchase of Common Stock
-0.27-0.09-0.27-0.25-0.15
Upgrade
Financing Cash Flow
-0.210.39-0.2285.2818.58
Upgrade
Foreign Exchange Rate Adjustments
-0.06-0.02-0.01--
Upgrade
Net Cash Flow
-6.38-9.567.518.142.48
Upgrade
Free Cash Flow
-19.36-20.03-21.46-22.31-8.84
Upgrade
Free Cash Flow Margin
-1935.60%----
Upgrade
Free Cash Flow Per Share
-2.32-2.48-4.14-6.05-8.59
Upgrade
Levered Free Cash Flow
-13.07-14.36-14.11-15.45-13.09
Upgrade
Unlevered Free Cash Flow
-13.07-14.36-14.11-15.45-13.09
Upgrade
Change in Net Working Capital
0.890.52-0.47-0.72.43
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q